{"id": 225003664, "title": "Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules", "text": "www.optimihealth.ca ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) Optimi Health Corp. is a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as psilocybin and MDMA, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of producing scalable psychedelic formulations for transformational human experiences, the Company\u2019s goal is to be the number one trusted, compassionate supplier of safe drug candidates throughout the world. Optimi\u2019s products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia. FORWARD\u2010LOOKING STATEMENTS This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, \u201cforward-looking statements\u201d) that relate to Optimi\u2019s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as \u201cwill likely result,\u201d \u201care expected to,\u201d \u201cexpects,\u201d \u201cwill continue,\u201d \u201cis anticipated,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimated,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cforecast,\u201d \u201cprojection,\u201d \u201cstrategy,\u201d \u201cobjective,\u201d and \u201coutlook\u201d) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. forward-looking statements made in this news release include the proposed use of the proceeds of the Offering. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.", "summary": "Company preparing to export 160 doses of MDMA and psilocybin under Australia\u2019s Authorized Prescriber Scheme VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) &#8212; Optimi Health Corp.\u00a0(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as psilocybin and MDMA, is pleased to announce that [&#8230;]", "url": "https://financialpost.com/globe-newswire/optimi-health-secures-import-permit-from-mind-medicine-australia-for-mdma-and-psilocybin-capsules", "image": "https://smartcdn.gprod.postmedia.digital/financialpost/wp-content/uploads/2024/05/commuters-on-bay-street-as-canadian-stocks-mixed.jpg?quality=5&strip=all&w=100&sig=gCsOruxPhrA8bPqdSVYb6g", "video": null, "publish_date": "2024-05-29 12:14:08", "author": "GlobeNewswire", "authors": ["GlobeNewswire"], "language": "en", "source_country": "CA", "sentiment": 0.24}